Vnitr Lek 1999, 45(11):673-676

[Results of the United Kingdom Prospective Diabetes Study and its importance in the treatment of hypertension in diabetics].

J Mertl
II. interní klinika FN U sv. Anny Brno.

In 1997 the United Kingdom Prospective Diabetes Study (UKPDS), the largest and longest study in type 2 diabetes so far, was finished. Answers to fundamental questions of non-insulin dependent diabetes mellitus therapy were expected: 1. What is the benefit from a good metabolic control of diabetes? 2. Has any particular antidiabetic therapy advantages over the other ones? 3. What is the importance of concurrent antihypertensive therapy? The evidence was given that intensive therapy (with antidiabetics or insulin) substantially and significantly reduced the risk of microvascular complications, but the reductions of mortality and macrovascular complications were not significant. An adverse cardiovascular effect of sulfonylureas or insulin were not confirmed. All intensive therapeutic approaches reached comparable results only metformin appeared to be advantageous first-line therapy of choice in obese diabetics. The intensive control of hypertension proved to be even more effective in prevention both the microvascular and namely the macrovascular complications as well as in reducing diabetes related mortality.

Keywords: Diabetes Mellitus, Type 2, therapy, ; Diabetic Angiopathies, prevention & control, ; Humans; Hypertension, prevention & control, ; Prospective Studies; Randomized Controlled Trials as Topic

Published: November 1, 1999  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mertl J. [Results of the United Kingdom Prospective Diabetes Study and its importance in the treatment of hypertension in diabetics]. Vnitr Lek. 1999;45(11):673-676.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.